In a 54-year-old female patient receiving intramuscular Abilify Maintena (aripiprazole) 400 mg every 28 days, what additional medication can be given to manage aggression?

Managing Aggression in a 54-Year-Old Female on Abilify Maintena 400mg IM

For aggression in a patient already on Abilify Maintena, consider adding valproate/divalproex sodium (starting at 125 mg twice daily, titrated to therapeutic levels of 40-90 mcg/mL) as a mood-stabilizing antiagitation agent, which is generally better tolerated than other options and serves as a useful alternative to adding another antipsychotic. 1

Clinical Reasoning

Since your patient is already receiving aripiprazole (Abilify Maintena) as a long-acting antipsychotic, adding another antipsychotic carries significant risks, particularly in a 54-year-old woman. The evidence guides us toward mood-stabilizing agents for persistent aggression and combativeness.

First-Line Adjunctive Options

Mood Stabilizers (Antiagitation Drugs):

• Divalproex sodium (Depakote) is specifically recommended for control of severe agitated, repetitive, and combative behaviors 1

  • Start: 125 mg twice daily
  • Titrate to therapeutic blood level: 40-90 mcg/mL
  • Key advantage: Generally better tolerated than other mood stabilizers
  • Monitoring required: Liver enzymes, platelets, PT/PTT as indicated

• Alternative: Carbamazepine (Tegretol) 1

  • Start: 100 mg twice daily
  • Titrate to therapeutic level: 4-8 mcg/mL
  • Critical caveat: Carbamazepine is a strong CYP3A4 inducer and should be avoided with Abilify Maintena for >14 days as it will significantly decrease aripiprazole levels 2
  • More problematic side effects than valproate
  • Requires CBC and liver enzyme monitoring

Second-Line Options for Acute Episodes

For breakthrough acute agitation:

• Lorazepam 1-2 mg (oral, IM, or IV) 3

  • Effective for acute agitation episodes
  • Important interaction: The FDA label warns that combining benzodiazepines with aripiprazole increases sedation intensity and orthostatic hypotension 2
  • Monitor sedation and blood pressure closely
  • Use lowest effective dose in this 54-year-old patient

• Trazodone for chronic management 1

  • Start: 25 mg daily
  • Maximum: 200-400 mg daily in divided doses
  • Use with caution if patient has cardiac history (premature ventricular contractions)

What to Avoid

Do NOT add typical antipsychotics (haloperidol, fluphenazine) - these carry significant risks in older adults including:

• 50% risk of tardive dyskinesia after 2 years of continuous use 1
• Severe extrapyramidal symptoms
• Cardiovascular and anticholinergic effects

Avoid adding another atypical antipsychotic - your patient is already on therapeutic aripiprazole, and polypharmacy with antipsychotics increases metabolic and neurological risks without clear benefit.

Avoid benzodiazepines for chronic management - while useful for acute episodes, regular use leads to tolerance, addiction, cognitive impairment, and paradoxical agitation in ~10% of patients 1. In older adults, recent evidence shows midazolam posed elevated risk of serious adverse events without efficacy gains 4.

Practical Implementation Algorithm

1. Assess aggression pattern: Is it persistent/chronic or episodic?

2. For persistent aggression:

   • Add valproate/divalproex 125 mg BID
   • Check baseline liver enzymes, CBC with platelets
   • Titrate every 5-7 days based on response and blood levels
   • Target therapeutic level: 40-90 mcg/mL

3. For episodic breakthrough agitation:

   • PRN lorazepam 0.5-1 mg (lower dose given age and interaction with aripiprazole)
   • Monitor for excessive sedation and orthostatic hypotension
   • Limit to infrequent use only

4. Monitor closely:

   • Blood pressure (aripiprazole has alpha-adrenergic antagonism) 2
   • Sedation level when combining medications
   • Liver function and hematologic parameters with valproate

Critical Safety Considerations

At age 54, this patient is approaching the age range where antipsychotic risks increase substantially. The FDA black box warning for Abilify Maintena specifically addresses increased mortality in elderly patients with dementia-related psychosis 2. While she may not yet be in this category, conservative medication management is prudent.

The combination of aripiprazole with lorazepam specifically increases sedation intensity and orthostatic hypotension beyond either agent alone 2, so if using benzodiazepines for acute episodes, start with lower doses (0.5-1 mg rather than standard 1-2 mg) and monitor carefully.